Bolt Biotherapeutics, Inc. - Common Stock (NQ:BOLT)

3.499 +0.049 (+1.42%)

Delayed Quote Updated: 3:59 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Bolt Biotherapeutics, Inc. - Common Stock

< Previous 1 2 3 Next >

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

October 02, 2025

Via Benzinga

Fidus Investment, Rocket Companies And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

October 02, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 02, 2025

Via Benzinga

Why Concorde International Group Shares Are Trading Higher By 55%; Here Are 20 Stocks Moving Premarket ↗

October 02, 2025

Via Benzinga

Looking Into Bolt Biotherapeutics's Return On Capital Employed ↗

March 30, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

October 01, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

August 28, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

August 27, 2025

Via Benzinga

Bolt Revenue Jumps 39 Percent in Q2 ↗

August 14, 2025

Via The Motley Fool

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

August 01, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

June 04, 2025

Via Benzinga

Stay updated with the stocks that are on the move in today's after-hours session. ↗

June 04, 2025

As the regular session of the US market concludes on Wednesday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.

Via Chartmill

BOLT Stock Earnings: Bolt Biotherapeutics Misses EPS, Beats Revenue for Q2 2024 ↗

August 13, 2024

BOLT stock results show that Bolt Biotherapeutics missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.

Via InvestorPlace

The Analyst Anxiety Index: 3 Stocks to Avoid as Uncertainty Grows ↗

May 24, 2024

Explore key stocks with analyst uncertainty to avoid amid contrasting global market highs and risky downgrades.

Via InvestorPlace

Why Bolt Biotherapeutics Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

May 15, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

May 15, 2024

Via Benzinga

This Accenture Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Today ↗

May 15, 2024

Via Benzinga

Why Arcutis Biotherapeutics Shares Are Trading Higher By 29%; Here Are 20 Stocks Moving Premarket ↗

May 15, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

May 15, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

May 15, 2024

We are covering the biggest pre-market stock movers for Wednesday with all of the latest happenings worth watching this morning!

Via InvestorPlace

BOLT Stock Earnings: Bolt Biotherapeutics Beats EPS, Beats Revenue for Q1 2024 ↗

May 14, 2024

BOLT stock results show that Bolt Biotherapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

May 14, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

April 03, 2024

Via Benzinga

BOLT Stock Earnings: Bolt Biotherapeutics Beats EPS, Beats Revenue for Q4 2023 ↗

March 21, 2024

BOLT stock results show that Bolt Biotherapeutics beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.

Via InvestorPlace

Why AERWINS Technologies Shares Are Trading Higher By Around 90%; Here Are 20 Stocks Moving Premarket ↗

October 02, 2023

Gainers AERWINS Technologies Inc. (NASDAQ: AWIN) shares rose 90.2% to $0.2297 in pre-market trading. Aerwins Technologies is considering strategic alternatives for non-core operations including, not...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 12, 2023 ↗

May 12, 2023

Via Benzinga

Bolt Biotherapeutics Says Phase 1 Data Supports Advancing Into Phase 2 Studies ↗

March 30, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 11, 2022 ↗

August 11, 2022

Via Benzinga

SVB Leerink Cuts Price Target On This Stock By 50%, Also Check Out Some Other Major PT Changes ↗

August 11, 2022

SVB Leerink cut the price target on Bolt Biotherapeutics, Inc. (NASDAQ: BOLT) from $8 to $4. SVB Leerink analyst Daina Graybosch downgraded the stock from Outperform to Market Perform. Bolt...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

July 20, 2022

Gainers NeuroBo Pharmaceuticals (NASDAQ:NRBO) shares increased by 15.1% to $0.63 during Wednesday's after-market session. The company's market cap stands at $16.7 million.

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.